$0.4845
-0.0262-5.13%
마지막 업데이트: Nov 19, 2:48 PM

The average analyst price target for Citius Pharmaceuticals is $65, 13315.9% above the current price. Of 4 analysts, 3 rate it Buy and 1 Hold. Targets range from $4 to $150. The latest change came on May 18, 2026, when HC Wainwright & Co. assumed coverage of Citius Pharmaceuticals with a Buy rating and a $4 price target.
Price Target Range — 10 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months